Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2015 Dec;39(12):1360-6.
doi: 10.1016/j.leukres.2015.09.015. Epub 2015 Sep 24.

Impact of telomere length on survival in classic and variant hairy cell leukemia

Affiliations
Comparative Study

Impact of telomere length on survival in classic and variant hairy cell leukemia

Evgeny Arons et al. Leuk Res. 2015 Dec.

Abstract

Telomeres, which protect the ends of chromosomes, are shortened in several hematologic malignancies, often with adverse prognostic implications, but their effect on prognosis of classic and variant hairy cell leukemia (HCL and HCLv) has not been reported. HCL/HCLv genomic DNA from 46 patients was studied by PCR to determine the ratio of telomere to single copy gene number (T/S). T/S was unrelated to diagnosis of HCL or HCLv (p=0.27), but shorter T/S was associated with unmutated immunoglobulin rearrangements (p=0.033) and age above the median at diagnosis (p=0.017). Low T/S was associated with shorter overall survival from diagnosis (OS), particularly T/S <0.655 (p=0.0064, adjusted p=0.019). Shorter OS was also associated with presence of unmutated (p<0.0001) or IGHV4-34+ (p<0.0001) rearrangements, or increasing age (p=0.0002). Multivariable analysis with Cox modeling showed that short T/S along with either unmutated or IGHV4-34+ rearrangements remained associated with reduced OS (p=0.0071, p=0.0024, respectively) after age adjustment. While T/S is relatively long in HCL and the disease usually indolent with excellent survival, shortened telomeres in HCL/HCLv are associated with decreased survival. Shortened T/S could represent a risk factor needing further investigation/intervention to determine if non-chemotherapy treatment options, in addition to or instead of chemotherapy, might be particularly useful.

Keywords: Chromosomes; DNA damage; Hairy cell leukemia; Molecular marker; Telomere.

PubMed Disclaimer

Figures

Figure 1
Figure 1. T/S ratios
27 HCL and 19 HCLv patients. Median values, indicated by horizontal bars, were 0.47 for HCL and 0.40 for HCLv.
Figure 2
Figure 2. Overall survival from diagnosis
In A, according to age at diagnosis in three categories, in B, T/S ratio >0.655, or <0.655 combined with either mutated vs. un-mutated rearrangements, and in C, T/S ratio >0.655, or <0.655 combined with either IGHV4-34+ or negative rearrangements.

References

    1. Tiacci E, Trifonov V, Schiavoni G, Holmes A, Kern W, Martelli MP, et al. BRAF mutations in hairy-cell leukemia. N Engl J Med. 2011;364:2305–2315. - PMC - PubMed
    1. Falini B, Tiacci E, Liso A, Basso K, Sabattini E, Pacini R, et al. Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1) Lancet. 2004;363:1869–1870. - PubMed
    1. Matutes E. Immunophenotyping and differential diagnosis of hairy cell leukemia. Hematol Oncol Clin North Am. 2006;20:1051. - PubMed
    1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4. Vol. 2. World Health Organization; 2008.
    1. Goodman GR, Burian C, Koziol J, Saven A. Extended follow-up of patients with hairy cell leukemia after treatment with cladribine. J Clin Oncol. 2003;21:891–896. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources